Advertisement

Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1776 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
BioLamina–Lauxera: investment, 202309 investment €17m by Lauxera Growth I fund 2023-09-12
IO Biotech–SEVERAL: investment, 202308 private placement $75m with existing + new investors 2023-08-07
Crescendo Biologics–Andera Partners: investment, 202307 financing round totalling $32m incl existing investor Andera Partners 2023-07-24
Crescendo Biologics–SEVERAL: investment, 202307 financing round $32m with new investor Kreos Capital + all major existing investors 2023-07-24
Crescendo Biologics–Sofinnova: investment, 202307 financing round totalling $32m incl existing investor Sofinnova Partners 2023-07-24
Abionyx–NewCap: public relations, 202307 service existent by NewCap 2023-07-13
EG 427–SEVERAL: investment, 202307 financing round Series A €5m final closing bringing total Series A to €18m 2023-07-13
Tenpoint Therapeutics–SEVERAL: investment, 202307 financing round Series A $70m led by F-Prime Capital + Sofinnova Partners + British Patient Capital 2023-07-12
Tenpoint Therapeutics–Sofinnova: investment, 202307 financing round Series A totalling $70m incl existing + co-lead investor Sofinnova Partners 2023-07-12
Aphea.Bio–SEVERAL: investment, 202307 financing round Series C €70m led by Innovation Industries 2023-07-11
Flash Therapeutics–NewCap: public relations, 202307 service existent by NewCap 2023-07-06
Exeliom Biosciences–Auriga Partners: investment, 202306 financing round Series A extension totalling €8m incl existing + co-investor Auriga Partners 2023-06-30
Exeliom Biosciences–Biocodex: investment, 202306 financing round Series A extension totalling €8m incl existing + co-investor Biocodex 2023-06-30
Exeliom Biosciences–Capital Grand Est: investment, 202306 financing round Series A extension totalling €8m incl existing + co-investor Capital GE 2023-06-30
Exeliom Biosciences–Crescent Enterprises: investment, 202306 financing round Series A extension totalling €8m incl new + lead investor CE-Ventures 2023-06-30
Exeliom Biosciences–SEVERAL: investment, 202306 financing round Series A extension €8m + final closing at total of €18m 2023-06-30
Exeliom Biosciences–UI Investissement: investment, 202306 financing round Series A extension totalling €8m incl existing + co-investor UII 2023-06-30
Gleamer–Alize RP: public relations, 202306 service existent press contact Alize RP 2023-06-28
Gleamer–Crista Galli Ventures: investment, 202306 financing round Series B totalling €27m incl existing + co-investor Crista Galli Ventures 2023-06-28
Gleamer–Elaia Partners: investment, 202306 financing round Series B totalling €27m incl existing + co-investor Elaia 2023-06-28
Gleamer–France (govt): investment, 202306 financing round Series B totalling €27m incl existing + co-investor Bpifrance via Digital Venture + F3A 2023-06-28
Gleamer–Heal Capital: investment, 202306 financing round Series B totalling €27m incl new + co-lead investor Heal Capital 2023-06-28
Gleamer–MACSF: investment, 202306 financing round Series B totalling €27m incl existing + co-investor MACSF 2023-06-28
Gleamer–PERSON: investment, 202306 financing round Series B totalling €27m incl several European radiologists 2023-06-28
Gleamer–SEVERAL: investment, 202306 financing round Series B €27m led by Supernova Invest + co-led by Heal Capital 2023-06-28
Gleamer–Siparex: investment, 202306 financing round Series B totalling €27m incl existing + co-investor XAnge 2023-06-28
Gleamer–Supernova Invest: investment, 202306 financing round Series B totalling €27m incl new + lead investor Supernova Invest 2023-06-28
Gleamer–UI Investissement: investment, 202306 financing round Series B totalling €27m incl existing + co-investor UI Investissement 2023-06-28
Astraveus–AdBio Partners: investment, 202306 seed financing round totalling €16.5m incl lead investor AdBio Partners 2023-06-27
Astraveus–France (govt): investment, 202306 seed financing round totalling €16.5m incl co-investor Bpifrance Large Venture 2023-06-27
Astraveus–JnJ: investment, 202306 seed financing round totalling €16.5m incl co-investor JJDC Inc 2023-06-27
Astraveus–Merck (DE): investment, 202306 seed financing round totalling €16.5m incl co-investor M Ventures 2023-06-27
Astraveus–Optimum Strategic Communications: public relations, 202306 service existent by Optimum 2023-06-27
Astraveus–SEVERAL: investment, 202306 seed financing round €16.5m led by AdBio Partners 2023-06-27
Carthera–EU (govt): investment, 202306 financing round Series B totalling €37.5m incl co-investor EIC Fund 2023-06-27
Carthera–OTHER: investment, 202306 financing round Series B totalling €37.5m incl prominent undisclosed lead investor 2023-06-27
Carthera–Panakès Partners: investment, 202306 financing round Series B totalling €37.5m incl existing + co-investor Panakès Partners 2023-06-27
Carthera–Relyens: investment, 202306 financing round Series B totalling €37.5m incl existing + co-investor Relyens Innovation Santé (Turenne Santé) 2023-06-27
Carthera–SEVERAL: investment, 202306 financing round Series B €37.5m led by undisclosed investor 2023-06-27
Carthera–Supernova Invest: investment, 202306 financing round Series B totalling €37.5m incl existing + co-investor Supernova 2 Fund 2023-06-27
Carbios–SEVERAL: investment, 202306–202307 capital increase €122.4m+€18.4m with 4.8m+725k new shares at €25,32/share 2023-06-22
Sanofi–SandboxAQ: AI-based drug discovery, 202306 collab existent disclosed of Sanofi with AQBioSim 2023-06-22
Nuage Therapeutics–Asabys Partners: investment, 202306 seed financing round totalling €12m incl co-lead investor Asabys Partners 2023-06-20
Nuage Therapeutics–SEVERAL: investment, 202306 seed financing round €12m led by Sofinnova Partners + Asabys with Innvierte + BStartup 2023-06-20
Nuage Therapeutics–Sofinnova: investment, 202306 seed financing round totalling €12m incl co-lead investor Sofinnova Partners 2023-06-20
AAVantgarde Bio–SEVERAL: investment, 202306 financing round Series A €61m led by Atlas Venture + Forbion 2023-06-06
Sartorius–Waters: biopharma production technology, 202306– collab expansion integration of PATROL UPLC PAS with Resolute BioSMB platform 2023-06-05
4Pharma–BC Platforms: investment, 202306 acquisition €na of 4Pharma by BC Platforms 2023-06-01
Dualyx–Andera Partners: investment, 202305 financing round Series A totalling €40m incl new + co-lead investor Andera Partners 2023-05-15
Dualyx–SEVERAL: investment, 202305 financing round Series A €40m co-led by Fountain Heathcare Partners + Forbion + Andera Partners 2023-05-15
DiogenX–AdBio Partners: investment, 202305 financing round Series A totalling €27.5m incl existing + co-investor AdBio Partners 2023-05-10
DiogenX–Boehringer: investment, 202305 financing round Series A totalling €27.5m incl existing + co-lead investor Boehringer Ingelheim Venture Fund 2023-05-10
DiogenX–Juvenile Diabetes Research Foundation: investment, 202305 financing round Series A totalling €27.5m incl existing + co-investor JDRF T1D Fund 2023-05-10
DiogenX–Lilly: investment, 202305 financing round Series A totalling €27.5m incl new + co-investor Eli Lilly 2023-05-10
DiogenX–Omnes Capital: investment, 202305 financing round Series A totalling €27.5m incl new + co-investor Omnes 2023-05-10
DiogenX–Roche: investment, 202305 financing round Series A totalling €27.5m incl new + co-lead investor Roche Venture Fund 2023-05-10
DiogenX–SEVERAL: investment, 202305 financing round Series A €27.5m led by BIVF + Roche Venture Fund 2023-05-10
Evommune–SEVERAL: investment, 202304 financing round Series B $50m co-led by Arix Bioscience + EQT Life Sciences + SymBiosis 2023-04-26
Ariceum Therapeutics–Andera Partners: investment, 202304 financing round Series A extension totalling €22.75m incl new + co-lead investor Andera 2023-04-18
Ariceum Therapeutics–SEVERAL: investment, 202304 financing round Series A extension €22.75m bringing total Series A to €47.75m 2023-04-18
Alia Therapeutics–Indaco Venture: investment, 202304 seed financing round extension totalling €4.4m incl co-investor Indaco Bio 2023-04-17
Alia Therapeutics–SEVERAL: investment, 202304 seed financing round extension €4.4m led by Sofinnova Telethon Fund 2023-04-17
Alia Therapeutics–Sofinnova: investment, 202304 seed financing round extension totalling €4.4m incl existing + lead investor Sofinnova Telethon Fund 2023-04-17
Alentis Therapeutics–France (govt): investment, 202304 financing round Series C totalling $105m incl existing + co-investor InnoBio 2 Fund 2023-04-13
Alentis Therapeutics–Jeito Capital: investment, 202304 financing round Series C totalling $105m incl existing + lead investor Jeito Capital 2023-04-13
Alentis Therapeutics–SEVERAL: investment, 202304 financing round Series C $105m led by Jeito Capital with Novo Holdings + RA Capital 2023-04-13
Calida Therapeutics–AdBio Partners: investment, 202304c seed financing €2m from AdBio Partners 2023-04-06
Polyplus-transfection–Sartorius: investment, 202303– acquisition €2.4b of Polyplus by SSB from Archimed + Warburg Pincus et al 2023-03-31
Galapagos–Novalix: drug discovery services, 202303– collab 5 years in connection with acquisition of Galapagos Romainville by Novalix 2023-03-30
Galapagos–Novalix: investment, 202303– acquisition of Romainvaille operations of Galapagos by Novalix 2023-03-30
Deepc–SEVERAL: investment, 202303 financing round Series A €12m led by Sofinnova Partners 2023-03-28
Deepc–Sofinnova: investment, 202303 financing round Series A totalling €12m incl new + lead investor Sofinnova Partners 2023-03-28
Kiro (FR)–SEVERAL: investment, 202303 financing round Series A €13.8m led by Sofinnova Partners 2023-03-28
Kiro (FR)–Sofinnova: investment, 202303 financing round Series A totalling €13.8m incl new + lead investor Sofinnova Partners 2023-03-28
Lys Therapeutics–Michael J Fox Foundation: grant, 202303– funding >$600k for preclinical research of glunozumab for Parkinson’s disease 2023-03-15
Mediar Therapeutics–SEVERAL: investment, 202303c financing round Series A $85m co-led by NVF + Sofinnova Partners 2023-03-15
Mediar Therapeutics–Sofinnova: investment, 202303c financing round Series A totalling $85m incl co-lead investor Sofinnova Partners 2023-03-15
AlgoTherapeutix–France (govt): investment, 202303 financing round Series B totalling €20m incl existing + co-investor Innobio 2 Fund of Bpifrance 2023-03-14
AlgoTherapeutix–Omnes Capital: investment, 202303 financing round Series B totalling €20m incl existing + co-investor Omnes Capital 2023-03-14
AlgoTherapeutix–OTHER: investment, 202303 financing round Series B totalling €20m incl existing + new business angel investors 2023-03-14
AlgoTherapeutix–Relyens: investment, 202303 financing round Series B totalling €20m incl new + lead investor Relyens Innovation Santé 2023-03-14
AlgoTherapeutix–SEVERAL: investment, 202303 financing round Series B €20m led by Relyens Innovation Santé advised by Turenne Capital 2023-03-14
AlgoTherapeutix–UI Investissement: investment, 202303 financing round Series B totalling €20m incl new + co-investor FCPI Majycc Innovation Santé 2023-03-14
Provention Bio–Sanofi: investment, 202303– acquisition $2.9b cash temder offer for Provention Bio by Sanofi at $25/share ANNOUNCED 2023-03-13
Chiesi–Iktos: AI-based drug discovery, 202303 collab existent or prior to 3/23 2023-03-09
Galapagos–Iktos: AI-based drug discovery, 202303 collab existent or prior to 3/23 2023-03-09
Iktos–Debiopharm: investment, 202303 financing round Series A totalling €15.5m incl new + co-lead investor Debiopharm Innovation Fund 2023-03-09
Iktos–Merck (DE): investment, 202303 financing round Series A totalling €15.5m incl new + co-lead investor M Ventures 2023-03-09
Iktos–Omnes Capital: investment, 202303 financing round Series A totalling €15.5m incl co-investor Omnes Capital 2023-03-09
Iktos–SEVERAL: investment, 202303 financing round Series A €15.5m co-led by M Ventures + Debiopharm Innovation Fund 2023-03-09
Ono Pharmaceutical–Iktos: AI-based drug discovery, 202303 collab existent or prior to 3/23 2023-03-09
Pfizer–Iktos: AI-based drug discovery, 202303 collab existent or prior to 3/23 2023-03-09
Servier–Iktos: AI-based drug discovery, 202303 collab existent or prior to 3/23 2023-03-09
Teijin–Iktos: AI-based drug discovery, 202303 collab existent or prior to 3/23 2023-03-09
UCB–Iktos: AI-based drug discovery, 202303 collab existent or prior to 3/23 2023-03-09
Noema Pharma–SEVERAL: investment, 202303 financing round Series B CHF103m ($12m) co-led by Forbion + Jeito Capital 2023-03-07
Avilar Therapeutics–Sanofi: investment, 202302 seed financing round extension totalling $15m incl new investor Sanofi Ventures 2023-02-16
Avilar Therapeutics–SEVERAL: investment, 202302 seed financing round extension $15m bringing total seed round to $75m 2023-02-16
InDevR–Adjuvant Capital: investment, 202301 financing round Series B totalling $9m incl $4m from Adjuvant Capital 2023-01-17
InDevR–Mérieux: investment, 202301 financing round Series B totalling $9m incl $5m from bioMérieux in connection w partnership 2023-01-17
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page



Advertisement

Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x300px

» top